The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN

Overview of attention for article published in Frontiers in oncology, March 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 7,462 followers.

⭐ #5: The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN 👨‍⚕️👩‍⚕️ Jerry L. Spivak & Alison R. Moliterno Read here 👉 https://t.co/wQOUiOQOkp @JohnsHopkins @HopkinsMedicine #MPNsm #Myelofibrosis #HemOnc #Oncology

New article: The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN https://t.co/JjOLubBofo #MF #myelofibrosis #hematology https://t.co/1pIhxBI28p

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.